Limited coverage drugs – ticlopidine

Last updated on September 27, 2024
Generic name ticlopidine           
Strength 250 mg 
Form tablet

Special Authority criteria

Approval period

For use in secondary prevention of coronary, cerebral and peripheral vascular occlusion and embolization where patient has experienced failure on or intolerance to ASA.


Indefinite

Practitioner exemptions

  • None

Special notes

  • None

Special Authority requests